Frontage Holdings Corporation
FGHQF
$0.101
-$0.019-15.83%
| Weiss Ratings | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | D | |||
| Rating Factors | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.02 | |||
| Price History | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -69.08% | |||
| 2-Year Total Return | -69.08% | |||
| 3-Year Total Return | -83.71% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -37.65% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.16 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Jun 21, 2024 | |||
| 52-Week High Price (Date) | Apr 05, 2024 | |||
| Valuation | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 265.62M | |||
| Enterprise Value | 378.17M | |||
| Price/Earnings (TTM) | 36.07 | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -66.67% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.79 | |||
| Price/Book (Q) | 0.61 | |||
| Enterprise Value/Revenue (TTM) | 1.27 | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | 7.99 | |||
| Enterprise Value/EBIT | 22.85 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.03B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 610 232 0100 | |||
| Address | 700 Pennsylvania Drive Exton, PA 19341 | |||
| Website | www.frontagelab.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.53% | |||
| Profit Margin | 2.34% | |||
| Management Effectiveness | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.63% | |||
| Return on Equity | 1.74% | |||
| Income Statement | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 259.97M | |||
| Total Revenue (TTM) | 259.97M | |||
| Revenue Per Share | $0.13 | |||
| Gross Profit (TTM) | 74.25M | |||
| EBITDA (TTM) | 41.18M | |||
| EBIT (TTM) | 14.40M | |||
| Net Income (TTM) | 6.10M | |||
| Net Income Avl. to Common (TTM) | 6.10M | |||
| Total Revenue Growth (Q YOY) | 0.09% | |||
| Earnings Growth (Q YOY) | -106.58% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -109.09% | |||
| Balance Sheet | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 43.17M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 147.23M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 337.40M | |||
| Current Ratio (Q) | 1.276 | |||
| Book Value Per Share (Q) | $0.17 | |||
| Total Assets (Q) | 569.02M | |||
| Total Current Liabilities (Q) | 115.35M | |||
| Total Debt (Q) | 152.74M | |||
| Total Liabilities (Q) | 231.63M | |||
| Total Common Equity (Q) | 334.95M | |||
| Cash Flow | FGHQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -86.93M | |||
| Cash from Financing (TTM) | 18.56M | |||
| Net Change in Cash (TTM) | -34.53M | |||
| Levered Free Cash Flow (TTM) | 7.26M | |||
| Cash from Operations (TTM) | 32.99M | |||
